<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Layout Recreation </title>
</head>
<style>
@import url('https://fonts.googleapis.com/css2?family=Montserrat:ital,wght@0,100..900;1,100..900&display=swap');
</style>
<link rel="stylesheet" href="style.css">

<body>
    <ul>
        <li id="cor">CORRESPONDENCE</li>
        <li id="line">|</li>
        <li id="mon">NOV 13, 2024</li>
        <li id="line">|</li>
        <li id="fr">FREE</li>
    </ul>

    <h2>Activity of Research-Grade <br>Pemivibart against SARS-CoV-2 <br>Sublineages</h2>
    <h3>Q. Wang and Others</h3>

    <p>SARS-CoV-2 continues to evolve under immunologic pressure. A 
        <br>synthesized version of pemivibart, an anti-SARS-CoV-2 monoclonal 
        <br>antibody with recent emergency-use authorization, showed mixed 
        <br>activity against emerging variants.</p>

    <h3>Correction Pemivibart Activity against Recent SARS-CoV-2 JN.1 
        <br>sublineages</h3>
</body>
</html>